Alison Michelle Griffin

Title: The Innovative Contributions of Alison Michelle Griffin

Introduction

Alison Michelle Griffin is a notable inventor based in Worthing, GB. She has made significant contributions to the field of biotechnology, particularly in the development of processes related to clavulanic acid and amino acids. With a total of 2 patents, her work has had a meaningful impact on pharmaceutical manufacturing.

Latest Patents

Griffin's latest patents include a process for improving the manufacture of clavams, such as clavulanic acid. This patent discloses novel DNA sequences and new microorganisms capable of producing increased amounts of clavulanic acid. Another significant patent involves D-N-carbamoyl-amino acid amidohydrolase and hydantoinase. This patent provides processes for the production of a carbamoylase enzyme, which can convert a D-N-carbamoyl glycine by expressing recombinant DNA in a homologous host. It also includes specific recombinant DNA vectors that produce high levels of expression of the carbamoylase enzyme and/or hydantoinase enzyme.

Career Highlights

Throughout her career, Alison has worked with prominent companies in the pharmaceutical industry, including Glaxo Group Limited and SmithKline Beecham Corporation. Her experience in these organizations has allowed her to develop and refine her innovative processes.

Collaborations

Griffin has collaborated with notable professionals in her field, including Barry Barton and Robert John Neal. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Alison Michelle Griffin's contributions to biotechnology and her innovative patents demonstrate her commitment to advancing pharmaceutical manufacturing processes. Her work continues to influence the industry and inspire future innovations.